Pancreatic Cancer Research

ResearcherUniversity of British ColumbiaNo recent work listed

C. Bruce Verchere

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9262-0586; OpenAlex author ID A5026232706. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Islet amyloid polypeptide does not suppress pancreatic cancer. Last author DOI 10.1016/j.molmet.2023.101667↗
  2. TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells. Co-author DOI 10.1038/cgt.2012.46↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Austin J. Taylor · 1 shared paper, 2023 · strength 0.19
  2. James D. Johnson · 1 shared paper, 2023 · strength 0.19
  3. Janel L. Kopp · 1 shared paper, 2023 · strength 0.19
  4. David F. Schaeffer · 1 shared paper, 2023 · strength 0.19
  5. Mani Roshan Moniri · 1 shared paper, 2012 · strength 0.03
  6. Garth L. Warnock · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.